Pharmacology

(Tatiana/iStock via Getty Images Plus)

CPHI North America

Future drugs will need novel excipients: IPEC

By Jenni Spinner

An expert from the organization discusses ahead of his CPhI North America presentation how tomorrow’s drugs can’t all be formulated with yesterday’s excipients.

Pic:getty/marianvejcik

CPHI NORTH AMERICA 2022

US pharma hubs: The rising stars to watch

By Rachel Arthur

CPhI North America 2022 host city Philadelphia is set to become one of the world’s biggest cell and gene therapy manufacturing hubs. But it’s just one of many centers of innovation that are helping drive the US pharma and biopharma industry.

(Kenishirotie/iStock via Getty Images Plus)

People on the Move: July 2020

By Jenni Spinner

Our latest spotlight on new hires, promotions and awards involves Lonza, ChargePoint Technology, Ashfield, Current Health and other industry firms.

GettyImages/maxsattana

Charles River to buy MPI Research for $800m

By Flora Southey

Charles River Laboratories International says it is en route to ‘double its size in five years’ with the acquisition of non-clinical CRO MPI Research.

(Image: iStock/daizuoxin)

News in brief

BioDuro teams up with API developer Porton

By Melissa Fassbender

The San Diego-CA-based contract research, development, and manufacturing organization (CDMO), BioDuro, has announced a cooperation agreement with Porton Pharma Solutions.

GettyImages/Skarie20

Amneal expands NY site ahead of Impax merger

By Flora Southey

Amneal Pharmaceuticals expects to bring production of some Impax Laboratories’ drugs in-house through a 100,000 sq. ft. expansion at its site in New York state.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All